⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3236317 | 0.83 | CHRM2 (0.33) | — | |
| SCHEMBL4786241 | 0.83 | APEX1 (0.31) | — | |
| SCHEMBL4858440 | 0.83 | LMNA (0.31) | — | |
| SCHEMBL21333948 | 0.83 | PRKCA (0.33) | — | |
| SCHEMBL2633146 | 0.81 | BRD4 (0.31) | — | |
| SCHEMBL23355067 | 0.80 | LMNA (0.33) | — | |
| SCHEMBL18048861 | 0.80 | MGAM (0.35) | — | |
| SCHEMBL29407564 | 0.80 | — | — | |
| SCHEMBL28854141 | 0.80 | ALDH1A1 (0.35) | — | |
| SCHEMBL11272754 | 0.79 | TSHR (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024121267-A1 | PERFLUORINATED MICELLES AND MEDICAL USES THEREOF. | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2024-06-13 | — | — | WO | disclosed |
| CN-109970637-B | Aripiprazole hapten and application thereof in immunoassay | 詹森药业有限公司 | 2022-04-19 | — | — | CN | disclosed |
| CN-108484496-B | Aripiprazole hapten and application thereof in immunoassay | 詹森药业有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-107266432-B | Quetiapine haptens for immunoassays | 詹森药业有限公司 | 2020-05-12 | — | — | CN | disclosed |
| EP-1463479-A4 | OPSONIC MONOCLONAL AND CHIMERIC ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA | BIOSYNEXUS INC (US) | 2006-02-22 | — | — | EP | disclosed |
| EP-1465926-A4 | METHODS FOR BLOCKING OR ALLEVIATING STAPHYLOCOCCAL NASAL COLONIZATION BY INTRANASAL APPLICATION OF MONOCLONAL ANTIBODIES | BIOSYNEXUS INC (US) | 2006-02-08 | — | — | EP | disclosed |
| EP-1465926-A2 | METHODS FOR BLOCKING OR ALLEVIATING STAPHYLOCOCCAL NASAL COLONIZATION BY INTRANASAL APPLICATION OF MONOCLONAL ANTIBODIES | Biosynexus Incorporated (US) | 2004-10-13 | — | — | EP | disclosed |
| EP-1463479-A2 | OPSONIC MONOCLONAL AND CHIMERIC ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA | Biosynexus Incorporated (US) | 2004-10-06 | — | — | EP | disclosed |
| EP-1385997-A2 | SYSTEM AND METHOD FOR DETECTING AND QUANTIFYING NUCLEIC ACIDS USING COVALENT BINDING | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2004-02-04 | — | — | EP | disclosed |
| WO-2003063772-A2 | METHODS FOR BLOCKING OR ALLEVIATING STAPHYLOCOCCAL NASAL COLONIZATION BY INTRANASAL APPLICATION OF MONOCLONAL ANTIBODIES | BIOSYNEXUS INCORPORATED (US) | 2003-08-07 | — | — | WO | disclosed |
| EP-1015027-A2 | PROCESS FOR PREPARING CONJUGATE VACCINES INCLUDING FREE PROTEIN AND THE CONJUGATE VACCINES, IMMUNOGENS, AND IMMUNOGENIC REAGENTS PRODUCED BY THIS PROCEDURE | Lees, Andrew (US) | 2000-07-05 | — | — | EP | disclosed |
| WO-2000025812-A2 | METHOD FOR PREPARING SOLID PHASE CONJUGATE VACCINES | HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) | 2000-05-11 | — | — | WO | disclosed |
| EP-0918796-A1 | MONOCLONAL ANTIBODY WHICH AGGLUTINATES E. COLI HAVING THE CS4-CFA/I FAMILY PROTEIN | DEPARTMENT OF THE ARMY, U.S. GOVERNMENT (US) | 1999-06-02 | — | — | EP | disclosed |
| WO-1998030239-A2 | PROCESS FOR PREPARING CONJUGATE VACCINES INCLUDING FREE PROTEIN AND THE CONJUGATE VACCINES, IMMUNOGENS, AND IMMUNOGENIC REAGENTS PRODUCED BY THIS PROCEDURE | LEES ANDREW (US) | 1998-07-16 | — | — | WO | disclosed |
| WO-1998005687-A1 | MONOCLONAL ANTIBODY WHICH AGGLUTINATES E. COLI HAVING THE CS4-CFA/I FAMILY PROTEIN | DEPARTMENT OF THE ARMY, US GOVERNMENT (US) | 1998-02-12 | — | — | WO | disclosed |
| EP-0786087-A1 | POLYPEPTIDE-DENDRIMER COMPLEXES | DADE INTERNATIONAL INC. (US) | 1997-07-30 | — | — | EP | disclosed |
| WO-1997007398-A1 | POLYPEPTIDE-DENDRIMER COMPLEXES | DADE INTERNATIONAL INC. (US) | 1997-02-27 | — | — | WO | disclosed |
| EP-0635023-A4 | COVALENTLY CROSS-LINKED OLIGONUCLEOTIDES. | ISIS PHARMACEUTICALS INC (US) | 1996-03-20 | — | — | EP | disclosed |
| EP-0635023-A1 | COVALENTLY CROSS-LINKED OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993018052-A1 | COVALENTLY CROSS-LINKED OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 1993-09-16 | — | — | WO | disclosed |